Related Experiment Video
Updated: May 15, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts
Frederick G Hayden1, Masaharu Shinkai2, Tristan W Clark3
1Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville.
Ensitrelvir effectively prevents COVID-19 in household contacts when given within 72 hours of symptom onset. This study shows a significant reduction in infection rates with ensitrelvir compared to placebo for postexposure prophylaxis.
Area of Science:
- Virology
- Infectious Diseases
- Pharmacology
Background:
- Ensitrelvir is an oral protease inhibitor for treating COVID-19.
- No antivirals were previously approved for postexposure prophylaxis in COVID-19 household contacts.
Purpose of the Study:
- To evaluate the efficacy of ensitrelvir for preventing COVID-19 in household contacts.
- To assess ensitrelvir's safety as postexposure prophylaxis.
Main Methods:
- A double-blind, randomized, placebo-controlled trial.
- Participants received ensitrelvir or placebo within 72 hours of index patient's symptom onset.
- Primary endpoint: COVID-19 diagnosis by day 10 (RT-PCR positive and symptoms).
Main Results:
- Ensitrelvir significantly reduced COVID-19 incidence (2.9% vs. 9.0%, RR 0.33, P<0.001).
- Adverse event rates were similar between ensitrelvir and placebo groups (15.1% vs. 15.5%).
- No COVID-19-related hospitalizations or deaths were reported.
Conclusions:
- Ensitrelvir is effective in preventing COVID-19 in household contacts.
- Early administration of ensitrelvir within 72 hours is crucial for prophylaxis.
Related Concept Videos
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Sexually Transmitted Infections
Retroviruses
Subviral Agents
Cytomegalovirus Disease

